Urinary tract infections in the female patient.
Recent investigations into the pathogenesis of urinary tract infections have led to significant understanding of the interaction between uropathogens and the urogenital tract. This understanding provides the potential for the development of new types of therapy. A practical approach to the management of lower urinary tract infections in female patients is discussed, as are new therapies for nonbacterial cystitis, including the urgency-frequency syndrome.
Parsons
C L
CL
D000268:Adhesiveness; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000892:Anti-Infective Agents, Urinary / Q000627:therapeutic use; D001327:Autoimmune Diseases; D001424:Bacterial Infections / Q000188:drug therapy; D003556:Cystitis / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology; D004106:Dilatation; D005260:Female; D010861:Fimbriae, Bacterial / Q000502:physiology; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications; D008593:Menopause; D009092:Mucous Membrane / Q000502:physiology; D010502:Perineum / Q000382:microbiology; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy; D012008:Recurrence
D000900:Anti-Bacterial Agents; D000892:Anti-Infective Agents, Urinary